CERo Therapeutics has a total of 72 patents globally, out of which 7 have been granted. Of these 72 patents, more than 72% patents are active. Europe is where CERo Therapeutics has filed the maximum number of patents, followed by Japan and United States of America. Parallelly, United States of
Vincere Biosciences has a total of 16 patents globally. Of these 16 patents, more than 87% patents are active. Canada and Australia is where Vincere Biosciences has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the
Persephone Biosciences has a total of 46 patents globally, out of which 16 have been granted. Of these 46 patents, more than 65% patents are active. The United States of America is where Persephone Biosciences has filed the maximum number of patents, followed by Australia and Canada. Parallelly, United States
EnLiSense has a total of 7 patents globally, out of which 2 have been granted. Of these 7 patents, more than 85% patents are active. The United States of America is where EnLiSense has filed all their patents. Parallelly, United States of America seems to be the main focused R&D
Tvardi Therapeutics has a total of 51 patents globally, out of which 9 have been granted. Of these 51 patents, more than 96% patents are active. The United States of America is where Tvardi Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be
OrphoMed has a total of 81 patents globally, out of which 42 have been granted. Of these 81 patents, more than 72% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of OrphoMed. OrphoMed was founded in 2015.
Lipotrue has a total of 48 patents globally, out of which 15 have been granted. Of these 48 patents, more than 91% patents are active. Europe is where Lipotrue has filed the maximum number of patents, followed by Korea (South) and Australia. Parallelly, Europe seems to be the main focused
Ensoma has a total of 20 patents globally. Of these 20 patents, more than 80% patents are active. United States of America seems to be the main focused R&D centre and also is the origin country of Ensoma. Ensoma was founded in 2019. Ensoma is a biotechnology company. The company
Geltor has a total of 93 patents globally, out of which 17 have been granted. Of these 93 patents, more than 89% patents are active. United States of America is where Geltor has filed the maximum number of patents, followed by Europe and Korea (South). Parallelly, United States of America
Emalex Biosciences has a total of 55 patents globally, out of which 35 have been granted. Of these 55 patents, more than 92% patents are active. Israel is where Emalex Biosciences has filed the maximum number of patents, followed by Japan. Parallelly, United States of America is the origin country
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.